{"entity":{"type":"insider","cik":"0001862050","url":"/insider/0001862050","json_url":"/insider/0001862050.json","name":"HUSSAIN IQBAL J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":16,"first":"2021-06-04","last":"2026-02-03","span_basis":"filed_date"},"name_variants":[{"name":"HUSSAIN IQBAL J","source":"filing","n_filings":16,"first_seen":"2021-06-04","last_seen":"2026-02-03"}],"transactions":[{"id":6038260,"accession":"0001470831-26-000092","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001470831-26-000092","line_url":"/filing/0001470831-26-000092#line-5","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38951.0,"shares_display":"38,951","price_per_share":25.151,"price_display":"25.15","price_state":"stated","total_value":979656.601,"total_display":"979,656.60","total_whole":"979,657","shares_owned_after":57645.0,"shares_owned_after_display":"57,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-03","scope":"insider"},{"id":6038251,"accession":"0001470831-26-000092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000092","line_url":"/filing/0001470831-26-000092#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1010.0,"shares_display":"1,010","price_per_share":25.0109,"price_display":"25.01","price_state":"stated","total_value":25261.009,"total_display":"25,261.01","total_whole":"25,261","shares_owned_after":104376.0,"shares_owned_after_display":"104,376","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-03","scope":"insider"},{"id":4864347,"accession":"0001470831-25-000344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000344","line_url":"/filing/0001470831-25-000344#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":27.6392,"price_display":"27.64","price_state":"stated","total_value":165835.2,"total_display":"165,835.20","total_whole":"165,835","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider"},{"id":4151638,"accession":"0001470831-25-000263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000263","line_url":"/filing/0001470831-25-000263#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":22.4065,"price_display":"22.41","price_state":"stated","total_value":134439.0,"total_display":"134,439.00","total_whole":"134,439","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-16","scope":"insider"},{"id":5048401,"accession":"0001470831-25-000200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000200","line_url":"/filing/0001470831-25-000200#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":21.8501,"price_display":"21.85","price_state":"stated","total_value":131100.6,"total_display":"131,100.60","total_whole":"131,101","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-15","scope":"insider"},{"id":4399641,"accession":"0001470831-25-000189","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001470831-25-000189","line_url":"/filing/0001470831-25-000189#line-4","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":440000.0,"total_display":"440,000.00","total_whole":"440,000","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-10","filed_date":"2025-09-11","scope":"insider"},{"id":4399634,"accession":"0001470831-25-000189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-25-000189","line_url":"/filing/0001470831-25-000189#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":20.0051,"price_display":"20.01","price_state":"stated","total_value":400102.0,"total_display":"400,102.00","total_whole":"400,102","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-09","filed_date":"2025-09-11","scope":"insider"},{"id":4898369,"accession":"0001847903-25-000137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000137","line_url":"/filing/0001847903-25-000137#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":17.23,"price_display":"17.23","price_state":"stated","total_value":103380.0,"total_display":"103,380.00","total_whole":"103,380","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-15","scope":"insider"},{"id":4779437,"accession":"0001847903-25-000117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000117","line_url":"/filing/0001847903-25-000117#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":14.9278,"price_display":"14.93","price_state":"stated","total_value":89566.8,"total_display":"89,566.80","total_whole":"89,567","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-15","filed_date":"2025-07-17","scope":"insider"},{"id":4038551,"accession":"0001847903-25-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000114","line_url":"/filing/0001847903-25-000114#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":14.0182,"price_display":"14.02","price_state":"stated","total_value":168218.4,"total_display":"168,218.40","total_whole":"168,218","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-25","scope":"insider"},{"id":5008413,"accession":"0001847903-25-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000064","line_url":"/filing/0001847903-25-000064#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":311.0,"shares_display":"311","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":4354.0,"total_display":"4,354.00","total_whole":"4,354","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-02","scope":"insider"},{"id":4053768,"accession":"0001847903-25-000061","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001847903-25-000061","line_url":"/filing/0001847903-25-000061#line-4","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2080.0,"shares_display":"2,080","price_per_share":14.0056,"price_display":"14.01","price_state":"stated","total_value":29131.648,"total_display":"29,131.65","total_whole":"29,132","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-28","filed_date":"2025-04-29","scope":"insider"},{"id":4053763,"accession":"0001847903-25-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000061","line_url":"/filing/0001847903-25-000061#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3609.0,"shares_display":"3,609","price_per_share":14.0001,"price_display":"14.00","price_state":"stated","total_value":50526.3609,"total_display":"50,526.36","total_whole":"50,526","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-25","filed_date":"2025-04-29","scope":"insider"},{"id":4038546,"accession":"0001847903-25-000040","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000040","line_url":"/filing/0001847903-25-000040#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":16.4495,"price_display":"16.45","price_state":"stated","total_value":98697.0,"total_display":"98,697.00","total_whole":"98,697","shares_owned_after":105386.0,"shares_owned_after_display":"105,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":5179444,"accession":"0001847903-25-000033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001847903-25-000033","line_url":"/filing/0001847903-25-000033","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":16.177573,"price_display":"16.18","price_state":"stated","total_value":97065.438,"total_display":"97,065.44","total_whole":"97,065","shares_owned_after":106774.0,"shares_owned_after_display":"106,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider","n_lines":2},{"id":5221151,"accession":"0001847903-25-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000009","line_url":"/filing/0001847903-25-000009#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":15.29,"price_display":"15.29","price_state":"stated","total_value":91740.0,"total_display":"91,740.00","total_whole":"91,740","shares_owned_after":118265.0,"shares_owned_after_display":"118,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":2445874,"accession":"0001847903-24-000183","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000183","line_url":"/filing/0001847903-24-000183#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77705.0,"shares_display":"77,705","price_per_share":16.3922,"price_display":"16.39","price_state":"stated","total_value":1273755.901,"total_display":"1,273,755.90","total_whole":"1,273,756","shares_owned_after":125785.0,"shares_owned_after_display":"125,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-17","scope":"insider"},{"id":6164349,"accession":"0001847903-22-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-22-000064","line_url":"/filing/0001847903-22-000064#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4563.0,"shares_display":"4,563","price_per_share":3.9501,"price_display":"3.95","price_state":"stated","total_value":18024.3063,"total_display":"18,024.31","total_whole":"18,024","shares_owned_after":154712.0,"shares_owned_after_display":"154,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider"},{"id":6164346,"accession":"0001847903-22-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-22-000064","line_url":"/filing/0001847903-22-000064#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3725.0,"shares_display":"3,725","price_per_share":4.0674,"price_display":"4.07","price_state":"stated","total_value":15151.065,"total_display":"15,151.06","total_whole":"15,151","shares_owned_after":159275.0,"shares_owned_after_display":"159,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-04","scope":"insider"},{"id":4708410,"accession":"0000899243-21-022067","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-022067","line_url":"/filing/0000899243-21-022067","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001862050","owner_name":"HUSSAIN IQBAL J","owner_display_name":"HUSSAIN IQBAL J","owner_url":"/insider/0001862050","role":"Officer (General Counsel)","role_mark":"O","role_mark_label":"Officer (General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8500.0,"shares_display":"8,500","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":170000.0,"total_display":"170,000.00","total_whole":"170,000","shares_owned_after":5500.0,"shares_owned_after_display":"5,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847903","name":"Centessa Pharmaceuticals plc","url":"/issuer/0001847903","role":"Officer (Chief Legal Officer)","n_filings":16,"first_seen":"2021-06-04","last_seen":"2026-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001862050","retrieved_at":"2026-08-25T01:53:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}